Guangzhou
Guangzhou
Guangzhou, Gongdong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children | Maintenance Treatment; Rhabdomyosarcoma Recurrent | Not yet recruiting | Phase 2 | 2025-08-22 | NCT07137884 |